GLP-1 medications like Ozempic and Wegovy have skyrocketed in popularity for their effectiveness in weight loss and managing Type 2 diabetes. But as these drugs become household names, questions are surfacing about their long-term effects and risks. Are these breakthrough treatments a miracle solution to metabolic health, or could they be a ticking time bomb? This talk will dive into the science behind GLP-1 receptor agonists, explore the potential benefits and dangers, and examine the ethical implications of their widespread use. Additionally, we'll discuss how diet and lifestyle changes can naturally support your body’s own GLP-1 production and complement the use of these medications for better, more sustainable results. Join us for a balanced, evidence-based discussion on the future of these "miracle" drugs.

To be kept up-to-date on the date and time of this talk join our newsletter MPN Digest!